Work

Impact of key prognostic factors on long-term overall survival in BRAFV600-mutated metastatic melanoma patients treated with vemurafenib in the BRIM-3 study

Year: 2016

Type: article

Source: Melanoma Research

Authors: Axel Hauschild, Paul B. Chapman, Caroline Robert, James Larkin, J.B.A.G. Haanen, A. Ribas, David Hogg, Omid Hamid, P.A. Ascierto, Alberto Testori, Paul Lorigan, R. Dummer, J. A. Sosman, Keith T. Flaherty, Matthew Wongchenko, Yuchun Yan, I‐Fen Chang, S. Coleman, Ivor Caro, Grant A. McArthur

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3184043299

FWCI: 0.151

Cites:

Cited by: 2

Related to: